Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
H&R GmbH & Co. KGaA is a Germany-based manufacturer of chemical-pharmaceutical specialty products derived from crude oil. The company operates primarily through its Chemical-Pharmaceutical division, which accounts for 96% of group sales and is divided into ChemPharm Refining and ChemPharm Sales segments. The ChemPharm Refining segment produces over 800 innovative products like plasticizers, white oils, paraffins, petroleum jellies, lubricants, base oils, and process oils at refineries in Hamburg-Neuhof and Salzbergen. These high-quality, environmentally friendly items serve more than 100 industries, including cosmetics, pharmaceuticals, tires, building materials, and rubber. The ChemPharm Sales segment manages international production and sales activities abroad. A smaller Plastics division manufactures high-precision plastic parts, tools, and molds for automotive suppliers and medical technology sectors, with facilities in Germany, Eastern Europe, and Asia. Headquartered in Salzbergen, the company generates the majority of its revenue from Germany, supplemented by Europe and global markets. Founded in 1919 as Hansen & Rosenthal, H&R GmbH & Co. KGaA upholds a legacy of quality and customer focus in the commodity chemicals sector.
Operating margin is thin at 2.10%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 7.2% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
€1.20B
▼ -7.2% YoY
Net Income (TTM)
-€34M
▼ -385.0% YoY
Op. Margin
2.33%
▼ -0.6pp YoY
ROIC
3.26%
▼ -0.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€65M
▲ +114.6% YoY
Op. Cash Flow (TTM)
€121M
▲ +422.7% YoY
Net Debt
€111M
Cash & Equiv.
€72M
3Y CAGR: -7.6%
Continue Research